A randomized controlled trial comparing PF-06438179/GP1111 (an infliximab biosimilar) and infliximab reference product for treatment of moderate to severe active rheumatoid arthritis despite methotrexate therapy - Concepedia

Concepedia

Publication | Open Access

A randomized controlled trial comparing PF-06438179/GP1111 (an infliximab biosimilar) and infliximab reference product for treatment of moderate to severe active rheumatoid arthritis despite methotrexate therapy

DOI Full Paper Access

58

Citations

20

References

2018

Year

Stanley Cohen, Rieke Alten, Hideto Kameda, Tomas Hala, S. Radominski, Muhammad I. Rehman, Ramesh Palaparthy, Karl Schumacher, Susanne Schmitt, Steven Y. Hua,

Arthritis Research & Therapy

References

	Year	Citations

Page 1